LexDanaLexDanabeta
Inventor

BURKHARDT LAUFER

Inventor
DE

Overview

4→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C08LCompositions of macromolecular compounds9%
PatentTitleYear
12,594,345Degradable hyaluronic acid hydrogels202612,565,525IL-2 conjugates202612,246,070Hydrogel cross-linked hyaluronic acid prodrug compositions and methods202511,642,415Hydrogel cross-linked hyaluronic acid prodrug compositions and methods2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to ASCENDIS PHARMA AS (3)· patent assignee history
2023–2026Based in DE· patent location history
2026Patents assigned to ASCENDIS PHARMA ONCOLOGY DIV A/S (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASCENDIS PHARMA AS32023–2026
ASCENDIS PHARMA ONCOLOGY DIV A/S12026
Locations
LocationPatentsSpan
DE42023–2026